Pcn335 - Time Trends in Frontline Systemic Therapy Utilization for Chronic Lymphocytic Leukemia in the United States

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.417
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Frontline Therapy for Chronic Lymphocytic Leukemia: The Dilemma Continues

Clinical Cancer Research
Cancer ResearchOncology
2008English

Role of Chlorambucil in Combination or Not With Anti-Cd20 as Frontline Therapy in Chronic Lymphocytic Leukemia in "Real Life"

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Update on Therapy of Chronic Lymphocytic Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Time Trends in Pulmonary Embolism in the United States

Archives of Internal Medicine
2011English

Characterizing and Prognosticating Chronic Lymphocytic Leukemia in the Elderly: Prospective Evaluation on 455 Patients Treated in the United States

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Chronic Lymphocytic Leukemia in Pregnancy

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Anticoagulant Therapy in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Obinutuzumab in Chronic Lymphocytic Leukemia: Design, Development and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Progress in Novel Cellular Therapy Options for Chronic Lymphocytic Leukemia: The MD Anderson Perspective

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy